|
|
Crude Oil Gains Over 1%; US Economy Adds 130,000 Jobs In January
|
|
|
|
12 Health Care Stocks Moving In Wednesday's Intraday Session
|
|
|
|
Upstream Bio shares are trading lower. The company announced top-line results from the Phase 2 VALIANT clinical trial evaluating the safety and efficacy of verekitug in adults with severe asthma.
|
|
|
|
Upstream Bio Shows Asthma Drug Cuts Attacks By 56%, Stock Reacts
|
|
|
|
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
|
|
|
|
Upstream Bio Releases Topline Data From Phase 2 VALIANT Trial Of Verekitug For Severe Asthma, Meeting The Primary Endpoint Of Annualized Asthma Exacerbation Rate
|
|